Skip to content
healthcare.dev

EMGALITY

NDC 0002-1436, galcanezumab-gnlm, injection, solution, from Eli Lilly and Company.

Product NDC
0002-1436
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761063
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1436 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GALCANEZUMAB120 mg/mL
Package NDCNDC-11Package
0002-1436-11000021436111 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0002-1436-01)
0002-1436-61000021436612 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/33a147be-233a-40e8-a55e-e40936e28db0
  • NADAC price for package 00002143611

    GET /v1/drugs/nadac/00002143611

Use it

Look up 0002-1436 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1436 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-1436. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.